CUAMC
ICPT

China Universal Asset Management Company’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

China Universal Asset Management Company’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,071
Closed -$19.9K – 501
2023
Q3 		$19.9K Buy
1,071
+524
+96% +$5.93K 0.01% 298
2023
Q2 		$6.05K Sell
547
-14
-2% -$195 ﹤0.01% 354
2023
Q1 		$7.53K Buy
561
+140
+33% +$2.42K ﹤0.01% 330
2022
Q4 		$5.21K Buy
421
+142
+51% +$2.01K ﹤0.01% 296
2022
Q3 		$4K Buy
+279
New +$4.49K ﹤0.01% 313

China Universal Asset Management Company's ICPT Position: Q4 2023 in Review

China Universal Asset Management Company sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 1,071 shares — an estimated $19.9K sold.

China Universal Asset Management Company first reported a position in ICPT in Q3 2022 and held it in 5 quarters. The position peaked at $19.9K in Q3 2023. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.

  • China Universal Asset Management Company reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
  • China Universal Asset Management Company sold 1,071 Intercept Pharmaceuticals, Inc. shares in Q4 2023, an estimated $19.9K.
  • China Universal Asset Management Company first reported a position in Intercept Pharmaceuticals, Inc. in Q3 2022 and held it in 5 quarters.
  • China Universal Asset Management Company's Intercept Pharmaceuticals, Inc. position peaked at $19.9K in Q3 2023.
  • 0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.

Based on China Universal Asset Management Company's 13F filing for Q4 2023, filed 24 Jan 2024.